Dr. Kindler participated in a fellowship at the Memorial Sloan-Kettering Cancer Center, a facility that is dedicated to fighting all forms of cancer, after completing her internship and residency at the UCLA Medical Center. At the University of Chicago Medical Center, she is now developing research on new drugs that will help treat mesothelioma. Part of her interest in the treatment of mesothelioma came about when she lost her father to the disease in 2001. Dr. Kindler is also a member of the Executive Committee of the International Mesothelioma Interest Group (iMig) and serves on the Science Advisory Board of the Meso Foundation (formerly MARF).